The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 217 participants.

Also called NCT02231788

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 217 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02231788
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02231788. Randomized; no masking; primary purpose treatment. Start 2014-06 (actual); primary completion 2018-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy
Acronym
TENUVA-BP
Condition
Hypertension
Intervention (Drug)
Telminuvo®Tab. 40/2.5mg
Intervention (Drug)
Telmitrend®Tab. 80mg
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct02231788
Content hash
81f43bc92e90683e0be71c80203dd7ab3036d897707b49721c604d294125add3